Trevi is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions.
Artiva Biotherapeutics
2 followers
UNC Charlotte
13 followers
Colossal Biosciences
9 followers
School District of Philadelphia
5 followers
DECA
4 followers
Mentor Collective
4 followers
Discovery Life Sciences
3 followers
Teaching Lab
3 followers
Mineralys Therapeutics
3 followers
iGEM
1 follower
Immunome
2 followers
Thurgood Marshall College Fund
2 followers